河南省肿瘤医院Henan Cancer Hospital

该疾病的证据

依据官方公开数据来源筛选

1. Colorectal cancer

   Zhengzhou 郑州市

   国家临床重点专科

   • General Surgery（B 级） https://anti-cancer.com.cn/Mobile/Journal/ArticleIndex/2171

   已发表研究

   • Author Correction: Machine learning model-guided selective use of temporary diverting ileostomy in rectal cancer surgery: a randomized controlled trial. Nature communications, 2026
   • MAL2-driven lipid droplets as Trojan horses: Subverting immune surveillance to promote colorectal cancer liver metastasis. Cancer letters, 2026

   PubMed 收录了 2 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 Medical Oncology 获提名。

2. Breast cancer

   Zhengzhou 郑州市

   已发表研究

   • Spatial habitat radiomics predicts tertiary lymphoid structure status and identifies an IDO1(+) migratory dendritic cell axis in breast cancer. Journal for immunotherapy of cancer, 2026
   • In silico studies, synthesis, and biological evaluation of novel imidazopyridine-based CYP4Z1 inhibitors targeting breast cancer stem cells. European journal of medicinal chemistry, 2026

   另有 1 项已发表研究

   PubMed 收录了 3 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 Medical Oncology 获提名。

3. Lung cancer

   Zhengzhou 郑州市

   国家临床重点专科

   • Thoracic Surgery（B 级） https://www.anti-cancer.com.cn/Html/News/Articles/13202.html

   已发表研究

   • DONSON links tumor-cell survival to MIF-associated macrophage remodeling in small cell lung cancer. Apoptosis : an international journal on programmed cell death, 2026

   PubMed 收录了 1 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 Medical Oncology 获提名。

4. Liver cancer

   Zhengzhou 郑州市

   已发表研究

   • [TACE-HAIC versus HAIC combined with targeted immunotherapy for unresectable hepatocellular carcinoma: a propensity score-matched retrospective controlled study]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2026
   • Diagnostic performance of the 2024 LI-RADS nonradiation treatment response algorithm in hepatocellular carcinoma treated with locoregional plus immune-targeted therapy. European journal of radiology, 2026

   PubMed 收录了 2 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 Medical Oncology 获提名。

5. Stomach cancer

   Zhengzhou 郑州市

   已发表研究

   • Complete and durable remission in a patient with brain metastasis from gastric cancer treated with SRS followed by RC48 plus camrelizumab after progression on chemo-immunotherapy: a case report and literature review. Frontiers in immunology, 2026
   • The SLC35B2/YAP1 axis contributes to the inhibitory effects of CLIC-2-overexpressing cancer-associated fibroblast-derived exosomes on gastric cancer progression. Cellular signalling, 2026

   PubMed 收录了 2 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 Medical Oncology 获提名。

6. Esophageal cancer

   Zhengzhou 郑州市

   国家临床重点专科

   • Thoracic Surgery（B 级） https://www.anti-cancer.com.cn/Html/News/Articles/13202.html

   已发表研究

   • Liquid Biopsy and Nonendoscopic Biomarkers for Precision Early Detection of Esophageal Cancer: Evidence, Risk Stratification and Translational Challenges. Journal of Cancer, 2026
   • Ultrasound-, CT-, and MRI-based logistic regression models for the diagnosis of supraclavicular lymph node metastasis in esophageal squamous cell carcinoma. European journal of radiology, 2026

   另有 1 项已发表研究

   PubMed 收录了 3 篇关于该疾病、并提及这家医院的论文。

   同时上榜：在复旦榜中为 Medical Oncology 获提名。

7. Pancreatic cancer

   Zhengzhou 郑州市

   复旦专科声誉排行榜 2023

   • Medical Oncology 获提名 https://www.fdygs.com/news2023-1.aspx

   国家临床重点专科

   • General Surgery（B 级） https://anti-cancer.com.cn/Mobile/Journal/ArticleIndex/2171
   • Medical Oncology（B 级） https://www.anti-cancer.com.cn/Html/Hospitals/Main/Description.html

8. Bone and soft tissue sarcoma

   Zhengzhou 郑州市

   复旦专科声誉排行榜 2023

   • Medical Oncology 获提名 https://www.fdygs.com/news2023-1.aspx

   国家临床重点专科

   • Medical Oncology（B 级） https://www.anti-cancer.com.cn/Html/Hospitals/Main/Description.html